Regulus Therapeutics Inc. (RGLS)

NASDAQ: RGLS · Real-Time Price · USD

7.85

-0.13 (-1.63%)

At close: May 01, 2025, 3:59 PM

7.79

-0.76%

Pre-market: May 02, 2025, 05:37 AM EDT

Regulus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-46.36M	-30.04M	-28.32M	-27.81M	-15.73M	-18.59M	-48.71M	-71.91M	-81.84M
Depreciation & Amortization	-1.21M	227K	122K	459K	467K	931K	2.26M	2.52M	2.28M
Stock-Based Compensation	7.74M	2.8M	2.18M	2.92M	2.61M	2.29M	5.44M	7.64M	12.87M
Other Working Capital	-2.63M	228K	660K	660.7K	106.39K	-5.07M	1.12M	2.08M	-1.05M
Other Non-Cash Items	42K	-16K	-52K	46K	154K	2.13M	756K	600K	1.04M
Deferred Income Tax	n/a	n/a	n/a	-662K	n/a	n/a	148K	349K	666K
Change in Working Capital	-1.88M	257K	550K	914K	-41K	-6.58M	-3.17M	2.02M	8.1M
Operating Cash Flow	-41.67M	-26.77M	-25.53M	-24.13M	-12.54M	-19.82M	-43.27M	-58.77M	-56.88M
Capital Expenditures	-340K	-613K	-361K	-251K	-11K	-244K	-22K	-319K	-966K
Cash Acquisitions	n/a	n/a	14.76K	n/a	n/a	318K	n/a	16K	53K
Purchase of Investments	-83.64M	-4.9M	-32.76M	n/a	n/a	n/a	n/a	-55.69M	-65.11M
Sales Maturities Of Investments	48M	20M	18M	n/a	n/a	n/a	46.54M	69.94M	101.39M
Other Investing Acitivies	n/a	3K	-14.76K	n/a	-11	295.00	46.54M	-16K	-53K
Investing Cash Flow	-35.98M	14.49M	-15.12M	-251K	-11K	74K	46.52M	13.94M	35.31M
Debt Repayment	-1.38M	-3.3M	n/a	-80K	-9.62M	-2.24M	-3.05M	n/a	19.6M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3K	n/a	n/a	26K	5K	3K	1K	4K	310K
Financial Cash Flow	92.42M	11.82M	4.49M	53.74M	9.51M	39.93M	-2.83M	43.41M	20.55M
Net Cash Flow	14.76M	-461K	-36.16M	29.36M	-3.03M	20.19M	416K	-1.42M	-1.02M
Free Cash Flow	-42.01M	-27.38M	-25.89M	-24.38M	-12.55M	-20.07M	-43.3M	-59.09M	-57.85M